Inspira Bio-Pharm Private Limited, a active private limited company, was established on 28 October 2003 in Mumbai, Maharashtra, India. Engaging in pharmaceutical retailers & distributors within the trade sector, it holds CIN: U24230MH2003PTC142898. Registered under ROC Roc Mumbai. it is unlisted. It has an authorized capital of ₹2.50 M and a paid-up capital of ₹0.64 M.
It upholds a compliant status. Its leadership includes Onar Singh Sawai Singh Shekhawat (Director), Amit Chunnilal Jain (Director), Vivek Jajodia (Director). Past directors included Vishal Narayanprasad Jajodia, Siluvaimuthu Paul Rajaiah Nadar, Amit Chunnilal Jain. It holds no open charges and ₹3.00 Cr settled loans. Its latest AGM occurred on 30 September 2024, with the balance sheet filed on 31 March 2024. It is based at 102, Marine Chambers,11 New Marine Lines, Mumbai, Mumbai, Maharashtra, 400020.
U24230MH2003PTC142898
142898
28 October 2003
₹2.50 M
₹0.64 M
Roc Mumbai
Unlisted
Active
Explore comprehensive insights into Inspira Bio-Pharm Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Onar Singh Sawai Singh Shekhawat | Director | 04 Jan 2008 | Current |
| Amit Chunnilal Jain | Director | 19 Apr 2024 | Current |
| Vivek Jajodia | Director | 28 Oct 2003 | Current |
| Bhushan Pyarelal Jain | Director | 19 Apr 2024 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Director | 11 Jan 2008 | Past |
| Pramod Abcsdd | Director | 26 Nov 2007 | Past |
| Pramod Abcsdd | Additional Director | 29 Sep 2024 | Past |
| Pramod Abcsdd | Additional Director | 29 Sep 2024 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Inspira Bio-Pharm Private Limited, for the financial year ended 2024, experienced modest growth in revenue, with a 8.43% increase. The company also saw a substantial fall in profitability, with a 22.74% decrease in profit. The company's net worth Soared by an impressive increase of 20.32%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2024, Inspira Bio-Pharm had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
₹0
₹30,000,000.00
| Date | Lender | Amount | Status |
|---|---|---|---|
| 30 Jun 2010 | Canara Bank | ₹3.00 Cr | Satisfied |
Explore comprehensive loan charge details -
Unlock and access historical data on people associated with Inspira Bio-Pharm, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Inspira Bio-Pharm, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Inspira Bio-Pharm's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Progress on Inspira Bio-Pharm Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records. was documented.
Amit Chunnilal Jain was appointed as a Director was appointed as a Director on 19 Apr 2024 & has been associated with this company since 1 year 7 months . was recorded as a recent event.
Bhushan Pyarelal Jain was appointed as a Director was appointed as a Director on 19 Apr 2024 & has been associated with this company since 1 year 7 months . was recorded as a recent event.
Progress on Inspira Bio-Pharm Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Mumbai. was documented.
Progress on A charge registered on 30 Jun 2010 via Charge ID 10231343 with Canara Bank was fully satisfied on 24 Nov 2020. was documented.
A charge with Canara Bank of Rs. 30.00 M registered on 30 Jun 2010 with Charge ID 10231343 was modified on 09 Mar 2012. was recorded as a recent event.
The CIN of Inspira Bio-Pharm Private Limited is U24230MH2003PTC142898.
Inspira Bio-Pharm Private Limited is headquartered at 102, Marine Chambers,11 New Marine Lines, Mumbai, Mumbai, Maharashtra, 400020.
Inspira Bio-Pharm Private Limited was incorporated on 28 October 2003.
The current directors of Inspira Bio-Pharm Private Limited are
The primary industry of Inspira Bio-Pharm Private Limited is Trade.
Inspira Bio-Pharm Private Limited is unlisted.
The authorized capital of Inspira Bio-Pharm Private Limited is ₹2.50 M, and the paid-up capital is ₹0.64 M.
The compliance status of Inspira Bio-Pharm Private Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX